🔎 Trials Near Me

Početna › Intersticijske bolesti pluća › Arizona

Kliničke studije za Intersticijske bolesti pluća u državi Arizona

13 studija za Intersticijske bolesti pluća traži sudionike na lokacijama u državi Arizona.

Gradovi u državi Arizona

Službeni tekst studije (engleski)

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA027, Phoenix
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07179380

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Arizona Heart Rhythm Center, Phoenix
  • University of Arizona, Tucson
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT05798923

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

  • Phoenix, Phoenix
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07473700

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Tucson
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05878717

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Banner University Medical Center, Phoenix
  • Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
  • Arizona Pulmonary Specialists, Ltd., Scottsdale
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Banner Health - University Medical Center Phoenix, Phoenix
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Arizona, Tucson
U tijeku regrutacijaOpažajna studija
Od 21 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Arizona Pulmonary Specialists, Phoenix
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Banner University Medical Center Phoenix Lung Institute, Phoenix
  • Norton Thoracic Institute, Phoenix
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Arizona Pulmonary Specialists, Phoenix
U tijeku regrutacijaOpažajna studija
Od 18 do 80 godina · Oba spola · Ažurirano 26. lip 2026. · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Arizona, Scottsdale
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 20. ožu 2026. · NCT06751069

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • HonorHealth Research Institute, Scottsdale
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 12. stu 2025. · NCT05975983

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.